Bain Capital Private Equity Leads $600M Series B in Kailera Therapeutics

Health Care · United States · $600M

Bain Capital Private Equity led a $600 million Series B financing in Kailera Therapeutics, announced October 14, 2025, to advance the companys pipeline of GLP-1 obesity therapies toward global Phase 3 trials. Bain Capital Life Sciences had co-led Kailera's $400M Series A launch round a year earlier.